The therapeutic pipeline in migraine: What does the future hold?
Abstract
Migraine is one of the leading causes of disability globally. Despite advances in the available pharmacological options for its management, many patients still show a lack of response to these current therapeutics. As a consequence, it is important to explore new targets for the management of migraine and related headache disorders. In this review, we discuss evidence related to various novel targets that are in different stages of development as part of the current therapeutic pipeline in migraine management. These include recent studies that report the role of specific ion channels in migraine pathophysiology, including ATP-sensitive potassium channels (K ATP ), large conductance calcium- and voltage-activated potassium channels (BK Ca ), and transient receptor potential melastatin (TRPM) channels, specifically TRPM3 and TRPM8. Additionally, peptides secreted endogenously by hypothalamic nuclei have drawn attention, for example, oxytocin, orexins and prolactin have been signaled as possible systems for modulation with therapeutics. Here, we will assess preclinical validation studies, as well as clinical experimental and clinical trial data, and we will discuss some of the potential challenges with these targets and the future perspectives of these pipeline targets.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.